Memory Booster Maker Can't Forget FTC False Ad Suit
By Mike Curley ( July 25, 2019, 2:31 PM EDT) -- A Federal Trade Commission suit alleging Quincy Bioscience falsely advertised the effectiveness of its memory boosting supplement Prevagen can go forward after a New York federal judge rejected the company's argument that not enough of the FTC's commissioners voted to authorize the suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.